Surgcenter is a service oriented business model based on patient visits and range of available procedures. Mesoblast is a product developer with no distribution. Surgcenter can’t help with clinical trials except perhaps to channel already identified candidates, which pushes what it can contribute a bit further along than just offering a product distribution channel. There lies the possible basis for a JV or some sort of alliance.
If the CLBP indication has the RMAT designation, it will benefit from having a large number of clinical trial sites if it is considered for an AA (cf FDA’s guidance on AA for RMAT designated products). Surgcenter can offer that.
- Forums
- ASX - By Stock
- MSB
- Ann: Change in substantial holding
Ann: Change in substantial holding, page-33
-
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.02 |
Change
0.045(4.64%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 99.0¢ | $1.071M | 1.067M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 12037 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 78761 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 34343 | 1.005 |
17 | 108722 | 1.000 |
19 | 121306 | 0.995 |
13 | 184695 | 0.990 |
6 | 71842 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 111220 | 13 |
1.015 | 74993 | 15 |
1.020 | 67483 | 14 |
1.025 | 56912 | 8 |
1.030 | 50481 | 9 |
Last trade - 10.54am 04/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online